Aprea Therapeutics, Inc. (APRE)

0.7943 -0.01 (-1.49%) USD  |  NASDAQ  |  Sep 04, 16:00
0.7902 0.00 (0.00%) After-Hours: 20:00
More

Aprea Therapeutics Cash and Short Term Investments (Annual) : 14.60M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 14.60M
December 31, 2024 22.85M
December 31, 2023 21.61M
December 31, 2022 28.79M
December 31, 2021 53.08M
Date Value
December 31, 2020 89.02M
December 31, 2019 130.09M
December 31, 2018 65.68M
December 31, 2017 24.40M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Zymeworks, Inc. 228.80M
Rhythm Pharmaceuticals, Inc. 388.95M
Onconetix, Inc. 5.221M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B